Vitalhub Corp. (TSE:VHI - Free Report) - Equities research analysts at Roth Capital issued their Q1 2026 earnings per share (EPS) estimates for Vitalhub in a research note issued on Monday, March 31st. Roth Capital analyst R. Baldry expects that the company will earn $0.06 per share for the quarter. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. Roth Capital also issued estimates for Vitalhub's Q2 2026 earnings at $0.06 EPS, Q3 2026 earnings at $0.07 EPS, Q4 2026 earnings at $0.07 EPS and FY2026 earnings at $0.26 EPS.
A number of other analysts have also issued reports on the stock. Raymond James set a C$13.50 target price on shares of Vitalhub and gave the company an "outperform" rating in a research note on Thursday, March 27th. Canaccord Genuity Group upped their target price on shares of Vitalhub from C$12.00 to C$12.50 and gave the stock a "buy" rating in a research note on Thursday, January 16th. TD Securities lifted their price target on shares of Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a research note on Monday, March 31st. Finally, Scotiabank set a C$14.00 price objective on Vitalhub and gave the stock an "outperform" rating in a research note on Thursday, January 30th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of C$12.08.
Read Our Latest Research Report on VHI
Vitalhub Stock Performance
Vitalhub stock traded down C$0.10 during mid-day trading on Wednesday, hitting C$9.60. The company's stock had a trading volume of 165,576 shares, compared to its average volume of 145,793. The company has a 50 day moving average of C$10.30 and a 200-day moving average of C$10.38. Vitalhub has a one year low of C$5.80 and a one year high of C$12.09. The stock has a market cap of C$519.29 million, a PE ratio of 156.14, a P/E/G ratio of 1.18 and a beta of 1.26.
About Vitalhub
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
